Bulk purchase eliqlustat (cerdelga) 84MG oral capsule
Ended Awarded Last action
- Contract number
- 36C26021F0236
- Awardee
-
Genzyme Corporation UEI X2XMAQLR9DA8
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $212,340
Award facts
- Contract value 100% obligated
- $212,340.40 Current and potential, with all options
- Completion date
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02142, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$17,316 | |
| Original award | $229,656 |
About this award
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $212,340.40 firm fixed price delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract to Genzyme Corporation for the bulk purchase of 84mg oral capsules of Eliqlustat (Cerdelga). Performance will take place in Cambridge, Massachusetts with no set-aside designation applied. Genzyme Therapeutics Division, doing business as Sanofi Genzyme, will serve as the prime contractor to supply the specialty pharmaceutical to support treatment programs within VISN 20, which encompasses healthcare facilities in Massachusetts.
Quick answers
Who was awarded contract 36C26021F0236?
36C26021F0236 was awarded to Genzyme Corporation by Veterans Integrated Service Network 20 (Veterans Health Administration) on March 1, 2021.
How much is contract 36C26021F0236 worth?
The government has obligated $212,340 on 36C26021F0236.
Is contract 36C26021F0236 an order under another contract?
Yes. 36C26021F0236 is a delivery order under 36F79719D0153, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26021F0236 competed?
The extent of competition for 36C26021F0236 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award